Total n = 187 | MSSA (100, 53.5%) | Other bacteria (87, 46.5%) | p-value |
---|---|---|---|
Sex | M: 63 (63.0%) F: 37 (37.0%) | M:57 (65.5%) F: 30 (34.5%) | 0.761(2) |
Age | 67 [23–90] y | 72 [47–89] y | 0.052(3) |
Spondylodiscitis | 57 (57.0%) | 68 (78.2%) | 0.003(2) |
Isolated spinal epidural empyema | 43 (43.0%) | 19 (21.8%) | |
Sepsis | 56/100 (56.0%) | 38/87 (43.7%) | 0.108(2) |
Septic embolism | 29/79 (36.7%) | 21/71 (29.6%) | 0.389(2) |
Endocarditis | 13/86 (15.1%) | 10/75 (13.3%) | 0.824(2) |
Relapse rate | 10/64 (15.6%) | 18/59 (30.5%) | 0.056(2) |
Disease-related mortality | 6/100 (6.0%) | 4/87 (4.6%) | 0.753(2) |
Length of hospital stay | 31 [9-163] d | 35 [10–165] | 0.182(3) |
Length of intensive care unit stay | 8 [1–53] d | 4 [1–46] d | 0.093(3) |
Spinal localization | |||
Cervical spine | 41 (41.0%) | 18 (20.7%) | 0.004(2) |
Thoracic spine | 45 (45.0%) | 30 (34.5%) | 0.178(2) |
Lumbar spine | 64 (64.0%) | 59 (67.8%) | 0.644(2) |
Bacterial detection via | |||
Blood cultures | 67 (67.0%) | 51 (58.6%) | 0.288(2) |
Intraoperative specimens | 87 (87.0%) | 70 (80.5%) | 0.238(2) |
CT-guided biopsies (37/65) | 23/41 (56.1%) | 14/24 (58.3%) | 1.0(2) |
Source of infection (129/187, 69.0%) | |||
Hematogenous spread | < 0.001(1) | ||
Gastrointestinal tract infection | 2/63 (3.2%) | 7/66 (10.6%) | |
Respiratory tract infection (pneumonia) | 9/63 (14.3%) | 7/66 (10.6%) | |
Urinary tract infection (urosepsis) | 3/63 (4.8%) | 10/66 (15.2%) | |
Skin infection | 26/63 (41.3%) | 11/66 (16.7%) | |
Foreign body-associated infection (joint replacements, venous access port, prosthetic heart valve, and screws elsewhere in spine) | 5/63 (7.9%) | 18/66 (27.3%) | |
Odontogenic infection | 4/63 (6.3%) | 1/66 (1.5%) | |
Retropharyngeal & prevertebral infection | 2/63 (3.2%) | 4/66 (6.1%) | |
Post-interventional | |||
Epidural administration such as spinal infiltration (facet joint, epidural, periradicular) or epidural catheter analgesia | 12/63 (19.0%) | 8/66 (12.1%) |